NCT03824002 is a Phase 4 clinical trial of Dulaglutide in Diabetes Mellitus, sponsored by University of Palermo.

Who is sponsoring NCT03824002?

NCT03824002 is sponsored by University of Palermo.

What drugs are being tested in NCT03824002?

Interventions in NCT03824002: Dulaglutide, Aspart insulin, Glargine, Metformin, Repaglinide.

What condition does NCT03824002 study?

NCT03824002 studies Diabetes Mellitus.

Is NCT03824002 still recruiting?

NCT03824002 is currently completed. Last updated 31 January 2019.

Last reviewed 2019-01-31 · How we verify

NCT03824002

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Dulaglutide in Diabetic Patients, Relationship Between Arterial Stiffness, Endothelial Function, Clinical and Laboratory Variables

Completed Phase 4 Last updated 31 January 2019

What this trial tests

Phase 4 trial testing Dulaglutide in Diabetes Mellitus in 92 participants. Completed in 20 April 2018.

Timeline

1 April 2017

Primary endpoint
1 October 2017

20 April 2018

Quick facts

Lead sponsor	University of Palermo
Phase	Phase 4
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	92
Start date	1 April 2017
Primary completion	1 October 2017
Estimated completion	20 April 2018
Sites	1 location across Italy

Drugs / interventions tested

Dulaglutide (DULAGLUTIDE) — full drug profile →
Aspart insulin
Glargine
Metformin (metformin) — full drug profile →
Repaglinide (repaglinide) — full drug profile →

Conditions studied

Diabetes Mellitus — all drugs for Diabetes Mellitus →

Sponsor

University of Palermo

Who can join

Adults 18 to 90, any sex, with Diabetes Mellitus. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study aims to evaluate arterial stiffness and endothelial function indexes and their relationship with clinic and laboratory varible in a group of diabetic patients in treatment with dulaglutide

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Efficacy of dulaglutide on vascular health indexes in subjects with type 2 diabetes: a randomized trial.
Tuttolomondo A, Cirrincione A, Casuccio A, Del Cuore A, et al · · 2021 · cited 39× · PMID 33397395 · DOI 10.1186/s12933-020-01183-5

Verify or expand the search:

Other trials of Dulaglutide

Trials testing the same drug.

NCT07417618 — INcreTin-based thERapies for Cardiovascular Event PrevenTion in Patients With and Without ASCVD (INTERCEPT-ASCVD) · active not recruiting
NCT07282041 — Role of GLP1 RA Dulaglutide on Severe Intracranial Atherosclerosis · Phase 2, PHASE3 · recruiting
NCT06851962 — Impact of Pharmacogenetic-Guided Treatment on Type 2 Diabetes. · Phase 4 · active not recruiting
NCT06779929 — Comparative Study of Tirzepatide Versus Dulaglutide (SURPASS CVOT) or Semaglutide on Major Cardiovascular Events in Part · completed
NCT07096063 — Comparative Effectiveness of Tirzepatide and Semaglutide in Individuals at Cardiovascular Risk · completed

Other recruiting trials for Diabetes Mellitus

Currently open trials in the same condition.

NCT07238556 — A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors · NA · recruiting
NCT07392437 — Prevalence of Diabetes-related Distress Among Patients Living With Type 2 Diabetes in a University Hospital Center and I · NA · recruiting
NCT07448805 — Accuracy and Safety of the Syai Tag System for Continuous Glucose Monitoring in Intensive Internal Care Unit · NA · recruiting
NCT07425275 — Integrated Oral Care Intervention for Xerostomia in Diabetes Patients · NA · recruiting
NCT06918977 — Improving Glycemic Control With Telemedicine and Smart Insulin Pens · NA · recruiting

Other University of Palermo trials

Trials by the same sponsor.

NCT03017716 — Inflammatory Back Pain and Gluten Free Diet · NA · not yet recruiting
NCT07364149 — Acute Effects of Structured Exercise and Static Stretching on Vascular Function, Neuromuscular Performance, and Metaboli · NA · recruiting
NCT06206616 — Liver Steatosis in Pediatric CD Patients · not yet recruiting
NCT07433543 — Foam Rolling, Blood Pressure and Range of Motion · NA · completed
NCT07213011 — Effects of Static Stretching and Self-myofascial Release on Local and Remote Range of Motion · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03824002 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Palermo
Last refreshed: 31 January 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03824002.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing